Fluid Chloride and AKI in Cardiopulmonary Bypass
Completed · Phase 2
Conditions studied: Acute Kidney Injury
In brief
Acute kidney injury (AKI) is a potential complication of cardiac surgery. In animal models, excess exogenous Cl- ion in the bloodstream is associated with AKI. Normal saline IV fluid has higher levels of Cl- ion than the blood usually carries. An alternative IV fluid sold under the name Isolyte has lower Cl- ion levels. There is no literature comparing AKI outcomes in cardiac patients between patients receiving normal saline vs. Isolyte. The investigators propose to recruit and randomize 30 trial-completing cardiac surgery patients (up to 40 enrolled) into 2 study arms and compare renal outcomes.
Key facts
- Study ID
- NCT02668952
- Run by
- University of New Mexico
- People needed
- 30
- Starts
- 2016-01-01
- Expected to finish
- 2018-02-01
- Last updated by the study team
- 2018-05-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Planned on- or off-pump cardiac surgery including: bypass grafting, valvular procedures, congenital defect correction, and thoracic aortic procedures or a combination of these procedures
You may not qualify if…
- Emergency surgery
- Pregnancy
- Previous renal transplantation
- Documented moderate to severe acute kidney injury prior to enrollment (e.g. RIFLE-I or RIFLE-F/KDIGO stage 2 or 3)
- Patients already receiving dialysis (acute or chronic) or in imminent need of dialysis at time of enrollment
- Chronic kidney disease without baseline serum creatinine value obtained within 6 months of enrollment
Where it is running
- University of New Mexico Hospital — Albuquerque, New Mexico, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.